Universidade NOVA de Lisboa, other four Portuguese Universities and a british university integrate a consortium that was recently awarded a grant of 15 million euros from the European Union for the implementation of a Center for Regenerative and Precision Medicine in Portugal, until 2024.
The Discoveries Centre for Regenerative and Precision Medicine (Discoveries CTR) gathers NOVA, Universidade do Minho, Universidade do Porto, Universidade de Aveiro, Universidade de Lisboa and University College of London, in the United Kingdom. The project received a EU Horizon 2020 TEAMING grant. The participation of NOVA in this project is assured by Instituto de Tecnologia Química e Biológica António Xavier e pelo CEDOC, Chronical Diseases Center from NOVA Medical School | Faculdade de Ciências Médicas.
«We believe the Discoveries Center can contribute exceptionally to the advancement of these fields of science, but also to increase Portugal’s capacity to attract top level scientists and to retain the best we have», said Paula Alves, the coordinator of ITQB NOVA participation.
Regenerative Medicine is an interdisciplinary research domain combining new therapeutic strategies in specific clinical contexts, aiming at regenerating tissues or organs lost or compromised either by trauma or by disease. Precision medicine is a novel way of disease treatment and prevention that takes into account individual variability of genes, environment and other factors, providing customised medical decisions and healthcare to each person. The Discoveries CTR project aims to lay the foundations of a multipolar distributed research centre in Portugal in these areas, grounded on the know-how of the consortium members.
The Discoveries CTR´s headquarters, including scientific and executive management, is located at the University of Minho. The center was officially launched in London, on the 5th of February.
Know more about this project in the website of ITQB NOVA.